| Autor: |
Fiat Felicia, Arnautu Diana-Aurora, Bernad Brenda Cristina, Anton Alina, Marcovici Iasmina, Semenescu Alexandra-Denisa, Bernad Elena Silvia |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
The Journal of Critical Care Medicine, Vol 10, Iss 1, Pp 73-84 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2393-1817 |
| DOI: |
10.2478/jccm-2024-0009 |
| Popis: |
Pregnant women manifest an increased risk of developing coagulation disorders. Unfractionated heparin (HEP) and low-molecular-weight heparin (LMWHep) are considered as selective medication in the case of pregnancy which needs anticoagulant treatment. In addition to anticoagulant properties, HEP and its derivatives manifest other properties including anti-cancer potential. According to Globocan’s latest data, colorectal cancer (CRC) is the second most encountered form of malignancy in the case of women, manifesting some special particularities, as confusion of symptoms from cancer with symptoms encountered normally in pregnant women (such as constipation or rectal bleeding), delayed diagnosis because of limitations imposed both for the fetus and for the mother, and the need for special treatment. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
